SELLAS Life Sciences Group Balance Sheet Health
Financial Health criteria checks 4/6
SELLAS Life Sciences Group has a total shareholder equity of $15.9M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $26.5M and $10.6M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$21.03m |
| Equity | US$15.89m |
| Total liabilities | US$10.61m |
| Total assets | US$26.51m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: RXK3's short term assets ($24.0M) exceed its short term liabilities ($10.6M).
Long Term Liabilities: RXK3 has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: RXK3 is debt free.
Reducing Debt: RXK3 had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: RXK3 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: RXK3 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 9.2% each year